Transcription Elongation Factor A (SII)-Like 1, also known as TCEANC, is a protein-coding gene that plays a crucial role in the transcription process. This protein is involved in the elongation phase of transcription, which is a critical step in the synthesis of RNA from a DNA template. The human recombinant form of this protein is used in various research and therapeutic applications.
The TCEANC gene encodes the Transcription Elongation Factor A (SII)-Like 1 protein. This gene is located on chromosome 1 and is composed of multiple exons that are transcribed into mRNA. The protein itself consists of several domains that are essential for its function in transcription elongation. These domains include the N-terminal and central domains, which are involved in the interaction with RNA polymerase II and other transcription factors .
The primary function of Transcription Elongation Factor A (SII)-Like 1 is to facilitate the elongation phase of transcription by RNA polymerase II. During transcription, RNA polymerase II can encounter obstacles that cause it to pause or backtrack. TCEANC helps to resolve these issues by inducing cleavage of the nascent RNA, allowing transcription to resume from the new 3’-terminus . This activity is crucial for the efficient and accurate synthesis of RNA molecules.
Transcription Elongation Factor A (SII)-Like 1 is essential for the proper regulation of gene expression. By ensuring the smooth progression of RNA polymerase II during transcription, TCEANC plays a vital role in the expression of genes involved in various cellular processes. Dysregulation of this protein can lead to transcriptional errors and has been associated with certain diseases, including infantile myofibromatosis .
The human recombinant form of Transcription Elongation Factor A (SII)-Like 1 is used in research to study the mechanisms of transcription elongation and its regulation. It is also utilized in therapeutic applications to investigate potential treatments for diseases caused by transcriptional dysregulation. The availability of recombinant TCEANC allows researchers to conduct experiments with a consistent and reliable source of the protein.